Genomic and transcriptomic features associated with responses and outcomes of third-generation ty...
November 13, 2026
Share
Genomic and transcriptomic features associated with responses and outcomes of third-generation tyrosine kinase-inhibitor therapy in chronic myeloid leukemia.